Company profile
Agilent Technologies, Inc.
NYSE: A · Healthcare · Medical - Diagnostics & Research
#47 of 1,418 Healthcare companies by revenue51st-percentile growth
EA Score
85AFH 88DQ 90GM 60SS 93
v0.1 · 65/100 weight · provisional
↑ Piotroski F, market scale · ↓ 3-yr revenue growth, revenue growth (YoY)
Methodology →Revenue TTM
$7.2B
Rev growth YoY (TTM)
+9.1%
Net income (FY)
$1.3B
Employees
18,100
as of 2026-08-04
Market cap
$39.5B
as of 2026-08-04
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$6.9B$6.9B2025
Net income$1.3B$1.3B2025
Operating income$1.5B$1.5B2025
Total assets$12.7B$12.7B2025
Liabilities$6.0B$6.0B2025
Equity$6.7B$6.7B2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Agilent CrossLab42%
Life Sciences and Applied Markets39%
Applied Markets19%
By geography
Americas40%
Asia Pacific32%
Europe28%
The read
What is Agilent Technologies, Inc.’s revenue?
Agilent Technologies, Inc. booked $6.9B in FY2025 revenue, growing 6.7% year over year — about the middle of the pack among Healthcare companies we track, at a 18.8% net margin.
Peers · Healthcare
Zoetis Inc.82B+Solventum Corporation65BZimmer Biomet Holdings, Inc.80B+Avantor, Inc.68BArdent Health Inc.61COrganon & Co.66BNeighbors
Santa Clara →Key facts
CEOPadraig McDonnell
SectorHealthcare
IndustryMedical - Diagnostics & Research
HeadquartersSanta Clara, CA
ExchangeNYSE: A
Employees18,100
IPO date1999-11-18
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.